Breast Cancer in Kenya: Incidence, Screening, Treatment and the Push for Earlier Diagnosis
Breast cancer is the most commonly diagnosed cancer in Kenya, with thousands of new cases recorded each year and a high proportion detected late. This overview examines the epidemiology, the national registry, screening, treatment access and the drive toward earlier diagnosis.
Malaria in Kenya: Epidemiological Zones, Treatment and Prevention
Malaria remains a major public-health burden in Kenya, concentrated in the lake and coastal zones. This guide explains the country's epidemiological zones, treatment with ACTs, prevention through nets and spraying, and the national malaria strategy.
Cervical Cancer in Kenya: Burden, HPV Vaccination, Screening Access and the Road to Elimination as a Public Health Problem
Kenya records about 5,250 new cervical cancer cases and 3,200 deaths a year. This article maps the HPV vaccination rollout, VIA screening, treatment access, the HIV link and the path toward WHO's 90-70-90 elimination targets.
Hypertension in Kenya: Burden, Diagnosis, Treatment Pathways and the Road to Population-Wide Blood Pressure Control
A deep look at hypertension in Kenya — covering disease burden, diagnosis at primary care level, treatment pathways under the Social Health Authority and the long road to population-wide blood pressure control across all 47 counties.
Sickle Cell Disease in Kenya: Prevalence, Newborn Screening, Treatment Access and the Lake and Coastal Burden
Sickle cell disease affects roughly 14,000 Kenyan newborns each year, concentrated in the lake and coastal counties. This article maps prevalence, newborn screening, hydroxyurea access, comprehensive care centres and the social and financing barriers families face across Kenya.
Type 2 Diabetes in Kenya: Prevalence, Diagnosis and Treatment Pathways
Type 2 diabetes is one of Kenya's fastest-growing chronic conditions, with national survey data showing a 3.1 percent adult prevalence, low awareness and a structural treatment gap that the National NCD Strategic Plan 2021-2026 is trying to close at primary-care level.
Kenya's National Tuberculosis Programme: Burden, Diagnosis and Treatment Access
Tuberculosis remains one of the leading causes of death from a single infectious agent in Kenya, but two decades of investment in the National Leprosy, Tuberculosis and Lung Disease Programme have substantially reduced incidence, mortality and undiagnosed cases.